[go: up one dir, main page]

NO20101223L - Prevention and treatment of HSMI - Google Patents

Prevention and treatment of HSMI

Info

Publication number
NO20101223L
NO20101223L NO20101223A NO20101223A NO20101223L NO 20101223 L NO20101223 L NO 20101223L NO 20101223 A NO20101223 A NO 20101223A NO 20101223 A NO20101223 A NO 20101223A NO 20101223 L NO20101223 L NO 20101223L
Authority
NO
Norway
Prior art keywords
hsmi
prevention
treatment
nutritional
cardiac
Prior art date
Application number
NO20101223A
Other languages
Norwegian (no)
Inventor
Kjell-Arne Rorvik
Rolf Kristian Berge
Henriette Alne
Magny Thomassen
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20101223A priority Critical patent/NO20101223L/en
Publication of NO20101223L publication Critical patent/NO20101223L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives anvendelse av en forbindelse for fremstilling av en ernæringsmessig og/eller farmasøytisk sammensetning for å redusere mortaliteten relatert til hjerte- og skjelettmuskelinflammasjon (HSMI) i fisk.The use of a compound for the preparation of a nutritional and / or pharmaceutical composition is described to reduce mortality related to cardiac and skeletal muscle inflammation (HSMI) in fish.

NO20101223A 2008-02-27 2010-09-02 Prevention and treatment of HSMI NO20101223L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20101223A NO20101223L (en) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20081040A NO20081040L (en) 2008-02-27 2008-02-27 Reduced HSMI mortality
PCT/NO2009/000069 WO2009108067A2 (en) 2008-02-27 2009-02-27 Prevention and treatment of hsmi
NO20101223A NO20101223L (en) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Publications (1)

Publication Number Publication Date
NO20101223L true NO20101223L (en) 2010-09-02

Family

ID=41003478

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20081040A NO20081040L (en) 2008-02-27 2008-02-27 Reduced HSMI mortality
NO20101223A NO20101223L (en) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20081040A NO20081040L (en) 2008-02-27 2008-02-27 Reduced HSMI mortality

Country Status (4)

Country Link
EP (1) EP2257282A2 (en)
CL (1) CL2009000460A1 (en)
NO (2) NO20081040L (en)
WO (1) WO2009108067A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO341929B1 (en) * 2009-09-14 2018-02-19 Chemoforma Ltd Feed composition
NO347765B1 (en) * 2012-11-01 2024-03-18 Ewos Innovation As Feed composition for fish

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2429711B (en) * 2004-06-11 2008-05-21 Pharmaq As Heart and skeletal muscle inflammation (HSMI) virus
ES2660700T3 (en) * 2004-07-19 2018-03-23 Bergen Teknologioverføring As Composition comprising vegetable and / or fish oils and non-oxidizable fatty acid entities
NO20055541L (en) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues

Also Published As

Publication number Publication date
EP2257282A2 (en) 2010-12-08
WO2009108067A2 (en) 2009-09-03
CL2009000460A1 (en) 2010-02-05
NO20081040L (en) 2009-08-28
WO2009108067A3 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
CU20140141A7 (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
ECSP13012668A (en) 1-BENCILCICLOALQUILCARBOXÍLICOS ACIDS SUBSTITUTED AND ITS USE
UY31228A1 (en) ARILOXAZOLES REPLACED AND ITS USE
CU24067B1 (en) ARILO COMPOUNDS WITH HETEROCYCLIC SUBSTITUTES AS HIF INHIBITORS
WO2009007412A3 (en) Age deglycation
PA8794401A1 (en) 6-PHENYLNICOTINIC ACIDS SUBSTITUTED AND ITS USE
UY31765A (en) SUBSTITUTED DIHYDROPIRAZOLONAS AND ITS USE
SV2009003098A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
MX2012004869A (en) Stable thickener formulations.
CR20110318A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS TO BE USED IN THE TREATMENT OF METABOLIC DISORDERS
ATE457729T1 (en) USE OF ALLOPURINOL FOR THE TREATMENT OF PALMAR/PLANTAR ERYTHRODYSAESTHESIA
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
IN2011KN05169A (en)
NO20101223L (en) Prevention and treatment of HSMI
NI201200196A (en) THERAPEUTIC AGENTS 976
AR081024A1 (en) ASSOCIATION OF XANTINE OXIDASE AND METFORMIN INHIBITORS AND THEIR USE
NO20075894L (en) Reduced maturation in fish
WO2015027669A3 (en) Phenyl-substituted compound, pharmaceutical composition and uses thereof
CL2011001399A1 (en) Morphine-6-glucuronide derived compounds; medicine; pharmaceutical composition comprising them; intermediate compounds; and its use in the treatment or prevention of pain.
EA201170138A1 (en) COMPOUNDS USED FOR THE PREVENTION OR TREATMENT OF ACCOMODATION ASTENOPIA
CN105029538A (en) Celery slimming soup
WO2012023058A3 (en) Sodium free food preservative
UY32429A (en) DERIVATIVES OF N - [(6-AZA-BICICLO [3.2.1] OCT-1-IL) -ARIL-METIL] -BENZAMIDA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
UY32428A (en) DERIVATIVES OF N - [(2-AZA-BICICLO [2.1.1] HEX-1-IL) -ARIL-METIL] -BENZAMIDA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application